Tell Congress: Prevent cancer deaths with early detection testing
- av: National Minority Quality Forum
- mottagare: U.S. Congress
We can prevent cancer deaths by catching cancer in its earlier stages. Congress is considering legislation - The Medicare MCED Screening Coverage Act (H.R. 1946/S. 1873) - that would create a pathway to Medicare coverage of early detection tests for cancer.
Your congressmember holds significant influence over this decision. We need you to make your voice heard right now!
Here are the facts:
Congress has the power to create a pathway that would allow for Medicare coverage of these early detection tests. The Medicare MCED Screening Coverage Act (H.R. 1946/S. 1873) would establish a new pathway for Medicare coverage of MCED tests following approval by the Food and Drug Administration (FDA). If this legislation is passed, this new coverage pathway would ensure that when MCED tests are approved by the FDA, seniors don't face unnecessary access delays.
Over 300 Members of Congress and 412 leaders in cancer advocacy agree: now is the time to pass this legislation! With only a handful of legislative days left this year, Congress must act to reduce missed cancer screenings by passing the Medicare MCED Screening Coverage Act.
Will you sign your name to this petition today to tell Congress to act?
Your congressmember holds significant influence over this decision. We need you to make your voice heard right now!
Here are the facts:
- Cancer screening tests covered by Medicare are currently limited to just five cancer types - breast, colorectal, prostate, lung, and cervical
- ~70% of the 600,000 cancer deaths each year are caused by cancer types that do not have screening tests available.
- Multi-cancer early detection (MCED) tests are innovative screening tests designed to detect many different cancer types in early stages. Some of these tests are capable of detecting dozens of cancers – helping to prevent cancer deaths by catching cancer in the crucial early stages.
Congress has the power to create a pathway that would allow for Medicare coverage of these early detection tests. The Medicare MCED Screening Coverage Act (H.R. 1946/S. 1873) would establish a new pathway for Medicare coverage of MCED tests following approval by the Food and Drug Administration (FDA). If this legislation is passed, this new coverage pathway would ensure that when MCED tests are approved by the FDA, seniors don't face unnecessary access delays.
Over 300 Members of Congress and 412 leaders in cancer advocacy agree: now is the time to pass this legislation! With only a handful of legislative days left this year, Congress must act to reduce missed cancer screenings by passing the Medicare MCED Screening Coverage Act.
Will you sign your name to this petition today to tell Congress to act?
Dear Congressmember,
As your constituents, we the undersigned are calling on you to prioritize cancer screening and early detection by passing the Medicare MCED Screening Coverage Act (H.R. 1946/S. 1873).
The Medicare MCED Screening Coverage Act (H.R. 1946/S. 1873) would create a pathway for coverage for MCED tests, once these tests are approved by the Food and Drug Administration (FDA) and reviewed by Medicare. This critical legislation would help increase access to early cancer screening for people who are on Medicare. We are calling on Congress to take action by passing H.R. 1946/S. 1873. Without this legislation, coverage of MCED tests could be delayed for years after FDA approval, and many people with Medicare may not be able to access these innovative tests. We are counting on Congress to ensure that our most vulnerable have access to promising, live-saving cancer screening tests.
Signed:
[your name]
Signera petitionenSignera petitionenAs your constituents, we the undersigned are calling on you to prioritize cancer screening and early detection by passing the Medicare MCED Screening Coverage Act (H.R. 1946/S. 1873).
- Cancer screening tests covered by Medicare are currently limited to just five cancer types - breast, colorectal, prostate, lung, and cervical.
- More than 9.5 million cancer screenings were missed as a result of the COVID-19 pandemic.
- ~70% of the 600,000 cancer deaths each year are caused by cancer types that do not have screening tests available.
- Multi-cancer early detection (MCED) tests are innovative blood-based screening tests designed to detect many different cancer types in early stages – often before symptoms occur. Some of these tests are capable of detecting dozens of cancers.
The Medicare MCED Screening Coverage Act (H.R. 1946/S. 1873) would create a pathway for coverage for MCED tests, once these tests are approved by the Food and Drug Administration (FDA) and reviewed by Medicare. This critical legislation would help increase access to early cancer screening for people who are on Medicare. We are calling on Congress to take action by passing H.R. 1946/S. 1873. Without this legislation, coverage of MCED tests could be delayed for years after FDA approval, and many people with Medicare may not be able to access these innovative tests. We are counting on Congress to ensure that our most vulnerable have access to promising, live-saving cancer screening tests.
Signed:
[your name]
Du har JavaScript inaktiverat. Utan den skulle vår webbplats inte fungera korrekt.
genom att skriva under accepterar du användarvillkor för Care2 Du kan hantera dina epostabonnemang när som helst.
Har problem med att skriva under detta? Låt oss veta.